Våra aktuella publiceringar
Här tar du del av våra publicerade artiklar inom Theranostics. Välkommen att kontakta oss för ytterligare information om våra resultat.
Boron Nanoparticle-Enhanced Proton Therapy: Molecular Mechanisms of Tumor Cell Sensitization
Ingår i Molecules, 2024
Ingår i Molecular Pharmaceutics, s. 1919-1932, 2024
Ingår i EJNMMI Radiopharmacy and Chemistry, 2024
2024
Evaluation of ABD-Linked RM26 Conjugates for GRPR-Targeted Drug Delivery
Ingår i ACS Omega, s. 36122-36133, 2024
Ingår i Pharmaceutics, 2024
Ingår i Journal of Controlled Release, s. 468-478, 2024
Ingår i International Journal of Molecular Sciences, 2024
MPS blockade with liposomes controls pharmacokinetics of nanoparticles in a size-dependent manner
Ingår i Biomedical Materials, 2024
Ingår i Cancers, 2024
- DOI för Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer
- Ladda ner fulltext (pdf) av Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer
Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion
Ingår i International Journal of Molecular Sciences, 2024
Ingår i EJNMMI Radiopharmacy and Chemistry, 2024
Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery
Ingår i Perspectives, 2024
Ingår i ACS Pharmacology & Translational Science, s. 1457-1473, 2024
Ingår i ACS Omega, s. 18608-18616, 2024
- DOI för Two Novel [68Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar11]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer
- Ladda ner fulltext (pdf) av Two Novel [68Ga]Ga-Labeled Radiotracers Based on Metabolically Stable [Sar11]RM26 Antagonistic Peptide for Diagnostic Positron Emission Tomography Imaging of GRPR-Positive Prostate Cancer
Ingår i Frontiers in Oncology, 2023
- DOI för 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
- Ladda ner fulltext (pdf) av 177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry
Ingår i American Journal of Nuclear Medicine and Molecular Imaging, s. 107-+, 2023
Comparison of HER2-targeted affibody conjugates loaded with auristatin-and maytansine-derived drugs
Ingår i Journal of Controlled Release, s. 515-527, 2023
Ingår i Journal of Controlled Release, s. 185-195, 2023
Development of a PNA-drug conjugate for pretargeted delivery of cytotoxic drugs
2023
Ingår i International Journal of Molecular Sciences, 2023
Ingår i Cancers, 2023
- DOI för Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors
- Ladda ner fulltext (pdf) av Phase I Trial of [Tc-99m]Tc-maSSS-PEG(2)-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors
Ingår i Cancers, 2023
- DOI för Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation
- Ladda ner fulltext (pdf) av Preclinical Characterisation of PSMA/GRPR-Targeting Heterodimer [Ga-68]Ga-BQ7812 for PET Diagnostic Imaging of Prostate Cancer: A Step towards Clinical Translation
Ingår i International Journal of Molecular Sciences, 2023
Preclinical evaluation of novel therapeutical GRPR-targeting antagonists labeled with 111In
2023
Ingår i Cancers, 2023
- DOI för Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
- Ladda ner fulltext (pdf) av Radionuclide Therapy of HER2-Expressing Xenografts Using [Lu-177]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab
Ingår i International Journal of Molecular Sciences, 2023
- DOI för Synthesis, I-123-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures
- Ladda ner fulltext (pdf) av Synthesis, I-123-Radiolabeling Optimization, and Initial Preclinical Evaluation of Novel Urea-Based PSMA Inhibitors with a Tributylstannyl Prosthetic Group in Their Structures
Ingår i Diagnostics, 2023
Ingår i Oncology Letters, 2023
- DOI för Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with Tc-99m and I-125
- Ladda ner fulltext (pdf) av Visualization of epithelial cell adhesion molecule-expressing renal cell carcinoma xenografts using designed ankyrin repeat protein Ec1 labelled with Tc-99m and I-125
Ingår i Pharmaceutics, 2022
Design, Synthesis, and Evaluation of Linker-Optimised PSMA-Targeting Radioligands
Ingår i Pharmaceutics, 2022
Ingår i International Journal of Molecular Sciences, 2022
- DOI för Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy
- Ladda ner fulltext (pdf) av Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy
Ingår i Pharmaceutics, 2022
Ingår i Pharmaceutics, 2022
In vitro characterization of affibody molecules intended for therapy of EGFR-expressing cancer
2022
PET-CT imaging of pulmonary inflammation using [Ga-68]Ga-DOTA-TATE
Ingår i EJNMMI Research, 2022
Ingår i Journal of Nuclear Medicine, s. 528-535, 2022
Ingår i Pharmaceutics, 2022
- DOI för Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
- Ladda ner fulltext (pdf) av Preclinical Evaluation of a New Format of Ga-68- and In-111-Labeled Affibody Molecule Z(IGF-1R:4551) for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT
Ingår i Biomedicines, 2022
- DOI för Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules
- Ladda ner fulltext (pdf) av Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules
The Performance of FDA-Approved PET Imaging Agents in the Detection of Prostate Cancer
Ingår i Biomedicines, 2022
A method of drug delivery to tumors based on rapidly biodegradable drug-loaded containers
Ingår i APPLIED MATERIALS TODAY, 2021
Ingår i Pharmaceutics, 2021
Ingår i Pharmaceutics, 2021
- DOI för Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain
- Ladda ner fulltext (pdf) av Comparative Preclinical Evaluation of HER2-Targeting ABD-Fused Affibody® Molecules 177Lu-ABY-271 and 177Lu-ABY-027: Impact of DOTA Position on ABD Domain
Ingår i Cancers, 2021
- DOI för Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
- Ladda ner fulltext (pdf) av Drug Conjugates Based on a Monovalent Affibody Targeting Vector Can Efficiently Eradicate HER2 Positive Human Tumors in an Experimental Mouse Model
Ingår i Diabetes, s. 842-853, 2021
Ingår i Scientific Reports, 2021
Ingår i Cancers, s. 4791-4791, 2021
- DOI för HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
- Ladda ner fulltext (pdf) av HER3 PET Imaging: 68Ga-Labeled Affibody Molecules Provide Superior HER3 Contrast to 89Zr-Labeled Antibody and Antibody-Fragment-Based Tracers
Ingår i Cancers, 2021
- DOI för Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
- Ladda ner fulltext (pdf) av Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model
Improved Radiolytic Stability of a 68Ga-labelled Collagelin Analogue for the Imaging of Fibrosis
Ingår i Pharmaceuticals, 2021
Ingår i Cancers, 2021
- DOI för Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1
- Ladda ner fulltext (pdf) av Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1